MSD KK manufactures and distributes conveyor equipment, pressed and welded parts for motorcycles and automobiles. The company was founded in 1929 and is headquartered in Yokohama, Japan.

Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.

Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom.

Kureha Corp. engages in the manufacture and sale of chemical products for pharmaceuticals, agrochemicals, and packaging materials. It operates through the following segments: Functional Products, Chemical Products, Resin Products, Construction-related Business, and Others. The Functional Products segment produces Polyphenylene Sulfide (PPS) resin, Polyvinylidene Fluoride, and carbon products. The Chemical Products segment develops and markets industrial chemicals, pharmaceutical products, and pesticides. The Resin Products segment includes food packaging materials and household goods. The Construction-related Business segment deals with construction and engineering services. The Others segment covers environmental-related businesses and logistics. The company was founded on June 21, 1944 and is headquartered in Tokyo, Japan.

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”

ISHIHARA SANGYO KAISHA LTD. engages in the manufacture and sale of industrial chemicals. It operates through the following business segments: Inorganic Chemicals, Organic Chemicals and Other Businesses. The Inorganic Chemicals segment produces and sells titanium dioxide, functional and electronic materials, and other inorganic chemicals. The Organic Chemicals segment deals with organic intermediates such as agrochemicals and active pharmaceutical ingredients. The Other Businesses segment includes trading and construction business. The company was founded by Hiroichiro Ishihara on September 10, 1920 and is headquartered in Osaka, Japan.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Ishihara Sangyo KK is a private company headquartered in Japan. The firm manufactures dies, tools and jigs.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Merck Sharp & Dohme LLC, part of Merck & Co., Inc., is a company headquartered in Kenilworth, NJ, that operates as a pharmaceutical company.

Zhejiang NHU Company Ltd. provides solutions for animal and human nutrition, medicine, health, environmental protection, and engineering plastics worldwide. It offers ingredients, vitamins, carotenoids, aroma chemicals, polymers, flavors and fragrances, etc.; and APIs and intermediates covering various areas, such as cardiovascular, anti-aids, anti-cancer, and anti-bacterial.

Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active pharmaceutical ingredients(APIs) in therapeutic areas including but not limited to Oncology, Cerebrovascular & Cardiovascular, Anti-infections, Psychological & Neurological Systems, Respiratory System, and Ophthalmological Diseases. Qilu has more than 15,000 employees, 70% of whom have a college degree or above. Qilu Pharmaceutical consistently focuses on revolutionary development strategies guided by market demand and product innovation. Qilu has established extensive cooperation with domestic and international partners on multiple R&D projects. Devoted to the cultivation of talent, Qilu has invested in a highly qualified R&D team and efficient R&D capabilities. The 200+ new drug products successfully developed by Qilu constitutes as a large part of future production and sales for Qilu Pharmaceutical and partners. A number of technological achievements have garnered national and provincial scientific and technological progress awards for Qilu.

Manufactures pharmaceuticals

Shandong Anhong Pharmaceutical Co., Ltd., established on 2009-06-01, Business scope includes pharmaceutical production;Drug Wholesale;Drug import and export;Drug Manufacturing;road freight transport.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China.

Shan Dong Cheng Hui Yi Yao Ji Tuan You Xian Gong Si, established on 2002-06-17, Business scope includes general items:Pharmaceutical intermediates and fine chemical products(Free of Hazardous Chemicals),food additives,Feed additives,Sales of experimental equipment;Research and development of new drugs,technology transfer,Pharmaceutical and chemical new technology and related technical consultation,Technical Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Goods and technology import and export business;General cargo road transport.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)